- Home
- ADCT vs CLW Comparison
ADCT vs CLW Comparison
Compare ADCT & CLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- CLW
- Stock Information
- Founded
- ADCT 2011
- CLW 2005
- Country
- ADCT Switzerland
- CLW United States
- Employees
- ADCT N/A
- CLW N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- CLW Paper
- Sector
- ADCT Health Care
- CLW Basic Materials
- Exchange
- ADCT Nasdaq
- CLW Nasdaq
- Market Cap
- ADCT 380.2M
- CLW 338.8M
- IPO Year
- ADCT 2020
- CLW N/A
- Fundamental
- Price
- ADCT $4.54
- CLW $19.88
- Analyst Decision
- ADCT Strong Buy
- CLW Strong Buy
- Analyst Count
- ADCT 6
- CLW 2
- Target Price
- ADCT $7.80
- CLW $33.00
- AVG Volume (30 Days)
- ADCT 1.1M
- CLW 199.1K
- Earning Date
- ADCT 11-06-2025
- CLW 11-03-2025
- Dividend Yield
- ADCT N/A
- CLW N/A
- EPS Growth
- ADCT N/A
- CLW 345.10
- EPS
- ADCT N/A
- CLW 12.12
- Revenue
- ADCT $77,246,000.00
- CLW $1,550,400,000.00
- Revenue This Year
- ADCT $13.47
- CLW $12.75
- Revenue Next Year
- ADCT $5.88
- CLW $1.60
- P/E Ratio
- ADCT N/A
- CLW $1.64
- Revenue Growth
- ADCT 15.73
- CLW 34.73
- 52 Week Low
- ADCT $1.05
- CLW $19.57
- 52 Week High
- ADCT $4.67
- CLW $33.57
- Technical
- Relative Strength Index (RSI)
- ADCT 74.76
- CLW 36.89
- Support Level
- ADCT $4.15
- CLW $19.57
- Resistance Level
- ADCT $4.67
- CLW $20.71
- Average True Range (ATR)
- ADCT 0.25
- CLW 0.62
- MACD
- ADCT 0.08
- CLW -0.07
- Stochastic Oscillator
- ADCT 82.86
- CLW 8.92
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.